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Summary 
Dehydrogenase (cortisol to cortisone) and oxoreductase (cortisone to cortisol) 
activities of porcine placental 11 R-hydroxysteroid ehydrogenase ( 11 l3-HSD) were 
measured in tissue fragment cultures on day 75 of gestation. Dehydrogenase activity 
was over fivefold greater than oxoreductase activity (p < ,001). There were positive 
linear associations (p < .Ol) between net dehydrogenase activity (dehydrogenase 
minus oxoreductase) and fetal weight, fetal length, and placental weight. These data 
indicate a predominance of placental 1 ll3-HSD dehydrogenase activity at this 
gestational stage that would insure a net conversion of cortisol to cortisone as it 
traverses the placenta. The data further suggest hat 1 I l3-HSD activities may provide 
an optimal glucocorticoid environment that is supportive of enhanced fetal and 
placental growth. 
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Many factors regulate the availability of biologically active cortisol to its target tissues. One such 
factor is the enzyme 1 lg-hydroxysteroid dehydrogenase that reversibly converts cortisol or corticos- 
terone to their biologically inactive 11 -keto metabolites cortisone and 11 -dehydrocorticosterone. 
In mineralocorticoid target tissues, 1 IB-HSD is responsible for insuring that glucocorticoids do not 
gain access to mineralocorticoid receptors (1, 2). In glucocorticoid target tissues, dehydrogenase 
activity of this enzyme may protect the tissues from excessively high concentrations of 
glucocorticoids or affect the response ofthese tissues to glucocorticoids (3). Conversely, reductase 
activity may be important in some tissues for ensuring optimum concentrations of biologically active 
glucocorticoids (4). It has been demonstrated that there are two predominant isoforms of 11%HSD. 
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1 lR-HSD Type I has both dehydrogenase and oxoreductase activities, uses NADP’ and NADPH 
respectively as coenzymes (5,6), and has K, values in the low /*M range for both dehydrogenase (7) 
and reductase activities (6). Under some conditions 1 ID-HSD Type I has predominantly oxoreduc- 
tase activity (7-9). 1 lR-HSD Type II is exclusively a NAD’-dependent dehydrogenase for naturally 
occurring substrates (10) and has a K, in the low nM range for cortisol(l1). 
The placenta expresses both 1 ll3-HSD isoforms in humans (12- 14), baboons (15), sheep (16), and 
rats (17). Placental 11 l3-HSD activity undoubtedly assists in providing an optimal glucocorticoid en- 
vironment for fetal tissues (18) as glucocorticoids are needed for final development of numerous 
tissues (19-20) whereas excessive concentrations cause fetal and placental growth retardation and 
fetal death (21-25). We have measured porcine placental 1 ll3-HSD dehydrogenase activity under 
optimum in vitro conditions of pH, substrate, and coenzyme concentration (26). Both NAD’ and 
NADP’-dependent dehydrogenase activities were present and increased between day 50 and 100 of 
gestation. Placental oxoreductase activity has not yet been reported for the porcine placenta. 
The ultimate influence of 1 ll3-HSD on accessibility ofmaternal cortisol to the fetal compartment and 
on cortisol effects on placental fimction is dependent upon the balance achieved between 1 lR-HSD 
oxidative and reductive activities. Hence, the current study was conducted to determine both de- 
hydrogenase and oxoreductase activities in porcine placentae under physiological conditions using 
placental explant culture and endogenous concentrations of coenzymes and substrate in a manner 
similar to those used by previous investigators (17-18,27-28). Tissue fragments were used because 
tissue homogenization causes significant loss of 1 ID-HSD oxoreductase activity in other species (27, 
28). Associations between fetal and placental size and placental 1 lB-HSD activity were also 
examined. 
Methods 
Animals. White crossbred gilts were bred naturally to boars of the same breed and were maintained 
in groups of lo-20 in swine confinement facilities at the Roman L. Hruska U.S. Meat Animal 
Research Center (MARC; Clay Center, NE) at a temperature of 18-22°C. Gilts received water ad 
libitum and 1. S-2.3 kg daily of a corn and soybean meal diet. Pregnant gilts were subsequently 
slaughtered on day 75 of gestation (term = 114 days) in the abattoir at MARC. This gestational age 
is midway in our previous study that demonstrated the presence of placental 1 l&HSD activity (26). 
Furthermore, it is at a gestational age when placental size has begun to plateau in white crossbred 
pigs (26, 29) whereas fetuses are still growing rapidly. Hence at this time, concentrations of 
placental enzymatic activities that influence fetal development might assume greater importance. 
Immediately after slaughter the reproductive tract was removed, taken to an adjacent room, and em- 
bryos with their placentae removed. Fragments (- 3 grams) of placentae from 7-8 fetuses from each 
of three gilts were removed and placed in ice cold sterile Eagle’s Minimum Essential Medium with 
Earle’s salts and L-Glutamine (Sigma, St. Louis, MO) to which had been added per liter: 2.2 g 
NaHCO,, 3 g l3-D glucose, 10 ml vitamins, 10 ml non-essential amino acids, 10 ml glutamine, and 10 
ml antibiotic/antimycotic solution (hereaRer eferred to as MEM; 30). Placental fragments were 
taken from the antimesometrial area at a point directly opposite to the site of the umbilicus. Fetuses 
and remaining placental tissue were then removed, weighed, and sex of fetuses noted. All procedures 
involving use of animals were reviewed and approved by our institution’s Animal Care and Use 
Committee. 
Tissue incubations. Working in a laminar flow hood and using sterile instruments, twelve fragments 
(- 40 mg each) were removed from each placenta, weighed, and placed into six tubes (two fragments 
each tube, 80 * 5 mg per tube) containing 1 ml of sterile MEM. tier a preincubation period of 10 
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min at 37T, .29 uCi of3H-cortisol (Amersham, Arlington Heights, IL) in 50 ul of MEM were added 
to one set of three tubes, and 29 uCi of 3H-cortisone (synthesized from 3-H cortisol; 3 1) were added 
to a second set of three tubes for each placenta. Placental samples were then incubated with constant 
gentle rocking in an atmosphere of 50% N,, 45% O,, and 5% CO, for 90 min at 37°C. Triplicate 
incubations with 3H-cortisone and 3H-cortisol in the absence of tissue were conducted to measure 
nonspecific conversions of substrate to product. Reactions were terminated by setting all tubes 
simultaneously in a tray of liquid nitrogen to rapidly freeze the incubates. Subsequently, samples 
were thawed and extracted with ethyl acetate to obtain tritiated steroids. These extracts were sub- 
jected to thin layer chromatography using chlorofonnmethanol (9: 1) as the solvent system, and 
zones corresponding to 3H-cortisol and 3H-cortisone were removed and counted in a liquid scintilla- 
tion counter. Tissue fragments were then washed twice in distilled water and once in sodium 
phosphate (.05 M) buffered saline (3 MNaCl) containing .02 M EDTA (PBS) to remove most radio- 
activity. Tissue fragments were then homogenized in PBS and aliquots removed for DNA analysis 
(32). 
In a preliminary study, placental tissue from one day-75 pregnant gilt was evaluated for product 
formation with time of incubation. Approximately 80 mg of tissue were incubated for IO, 20, 40, 
60, 120, or 240 min (triplicate incubations at each time period and for each substrate). For each time 
period, triplicate incubates without tissue were also conducted to measure nonspecific conversion 
of substrate to product. Approximately .25 &i of either ‘H-cortisol or 3H-cortisone were used as 
substrate. Incubations were conducted as above-noted and DNA measures conducted. 
Statisticalprocedures. All data are expressed as means + SEM. Data for experimental samples were 
analyzed by mixed model multifactorial nested analysis of variance using the SAS PROC MIXED 
procedure (33). Analyses of covariance to relate fetal measures to enzymatic activities were con- 
ducted using PROC MIXED. Effects of time on enzymatic activity were analyzed by ANOVA using 
PROC GLM (34). Data were tested for homogeneity of variance using an F,, test, and data were 
transformed to a log fimction where necessary to ti.~lfill assumptions of ANOVA. A probability level 
of 5 .05 was considered significant. 
Results 
In preliminary studies, 1 ll3-HSD dehydrogenase activity increased steadily between 10 and 120 min 
(p < .Ol) and then increased at a slower rate between 120 and 240 min (Fig. 1A). 1 ll3-HSD oxo- 
reductase activity was quite low during the first 60 min, increased dramatically between 60 and 120 
min (p < .Ol), and remained constant thereafter (Fig. 1B). Based on these results, subsequent incu- 
bations with experimental samples were conducted for 90 min for both dehydrogenase and oxoreduc- 
tase activity during the apparent ime period of initial velocity when the rate of product formation 
is proportional to the steady-state concentration of enzyme-substrate complex (35). 
Twelve male and 10 female fetuses were obtained from the three gilts. There were no differences 
in fetal weight or length, but placental weights were greater in male compared with female fetuses 
(Table I). 
Neither dehydrogenase nor oxoreductase activity was dependent on the sex of the fetus (p = ,064); 
therefore, data were combined across sexes. In the presence of endogenous substrate and co- 
enzymes, dehydrogenase activity was 5.4-fold greater (p < ,001) than oxoreductase activity (Fig. 2). 
Consequently, there was a net placental dehydrogenase activity (Fig. 2) that did not differ between 
sexes (p = .77). Significant gilt differences existed in enzymatic activity. Therefore for graphical pre- 
sentation of associations among fetal measures, activities within each gilt were converted to a percent 
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Fig. 1 
The relationship between time and 1 ll3-HSD dehydrogenase (3H-cortisol conversion 
to 3H-cortisone; A) or 1 lD-HSD oxoreductase (3H-cortisone conversion to 3H- 
cortisol; B) activities in porcine placental fragments. Each datum point represents the 
mean f SEM of triplicate determinations using 80 mg of day 75 porcine placental 
tissue and relying on endogenous concentrations of substrates and coenzymes. 
TABLE I 
Fetal Measures on Day 75 of Gestation.’ 
) Measure (n 
Fetal weight (grams) 12 272.7 f 20.7b 10 302.5 f 12.Sb 
Fetal length (mm) 12 185.9 f 5.4 b 10 196.4* 4.Sb 
Placental weight (grams) 12 99.7 f 10.ob 10 132.9 f 9.0” 
a Data represent mean f SEM. 
Means within a measure with different superscripts are different (p 2 .05). 
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Fig. 2 
Placental 1 IB-HSD dehydrogenase and oxoreductase activity on day 75 of gesta- 
tion. Net activity is the difference between dehydrogenase and oxoreductase activi- 
ty. Data represent the mean + SEM of the number of fetuses shown in parentheses. 
For oxoreductase activity, the SEM is too small to be visible at the scale used. 
of the maximal activity for that gilt. There were no linear relationships among fetal weight (p = .2 I), 
fetal length (p = .06), or placental weight (p = .37) and oxoreducatse activity. Fetal weight (b = .07 
grams/(fmol activity/l 00 pg DNA); p = .04) and fetal length (b = .02 mm/(fmol activity/l 00 pg 
DNA); p = .02), but not placental weight (b = .04 grams/(fmol activity/l 00 pg DNA); p = .06), were 
linearly associated with dehydrogenase activity. When associations. with net 1 ID-HSD activity (de- 
hydrogenase minus oxoreductase) were examined, linear associations existed for each measure (Fig. 
3 A,B,C): fetal weight (b = .09 grams/(fmol activity000 pg DNA); p < .OOl), fetal length (b = .02 
mm/(finol activity/100 pg DNA); p = < .OOl), and placental weight (b = .05 grams/(fmol activity/100 
pg DNA); p < 0.00 1). Statistical evaluations of graphically presented percent activity versus fetal 
or placental size provide similar interpretations (Fig. 3 A,B,C). 
Discussion 
This study demonstrates the presence of porcine placental 1 ID-HSD dehydrogenase and oxoreduct- 
ase activity at day 75 of gestation. At this stage and in the presence of endogenous coenzymes and 
substrate concentrations, dehydrogenase activity is greater than oxoreductase activity. A valid argu- 
ment could be made for addition of exogenous substrate to achieve saturating substrate concentra- 
tions that would obviate potential problems of varying endogenous substrate concentrations (35). 
However, our in vitro system was specifically designed in an attempt o duplicate in vivo conditions. 
Hence, no exogenous coenzymes or saturating substrate concentrations were added. Similar pro- 
cedures demonstrated close associations between 1 ID-HSD Type I and Type II activities and their 
corresponding mRNA expression (17). The current in vitro results correspond with in vivo data 
wherein maternal cortisol accounted for 50% of fetal cortisone at 50 and 100 days of gestation (36). 
At 100 days when tritiated cortisol was infbsed into the maternal circulation, fetal tritiated cortisol 
concentrations were less than 20% oftritiated cortisone concentrations (36). Maternal plasma corti- 
sol exceeded fetal plasma cortisol and fetal umbilical arterial cortisol exceeded umbilical venous corti- 
sol at day 75 of gestation (37). Together, these data provide evidence that under in vivo conditions 
at this gestational stage, dehydrogenase activity predominates, and as maternal and fetal cortisol 
traverses the placenta net dehydrogenase activity insures much of its conversion to cortisone. 
1050 11fLHSD in Porcine Placenta 
b 4.60 grams I % Activity 
p <o.ool 
100 q 
so I 
40 50 60 70 80 90 100 110 
b=0.47mml% Activity 
pcQ.001 
1254 1 
40 so 60 70 80 90 100 110 
NO- 
0 
0 b=O.!Mgrams I% Activity 
so- p<o.ool 
u 
0-T 1 
40 so 60 70 80 90 100 110 
Vol. 66, No. 11,200O 
Percent Net lip-HSD Dehydrogenase Activity 
Fig. 3 
Associations between fetal weight (A), fetal length (B), or placental weight (C) and 
placental 1 ID-HSD net dehydrogenase activity. For graphical representation, the en- 
zymatic activity for each fetal placenta was expressed as a percent of the maximal pla- 
cental activity measured within the pregnant pig from which the fetus came. Slopes 
(b) of linear regressions between size and percent 11 R-HSD activity are indicated. 
We were unable previously to show a relationship between placental 11 R-HSD dehydrogenase ac- 
tivity and fetal or placental size using different assay procedures (26). In this new study, there was 
a positive, linear relationship between 11 l3-HSD dehydrogenase activity and fetal and placental size, 
especially when net activity was considered. Such relationships suggest that an optimal glucocorti- 
coid environment, which is in part provided by 11lLHSD dehydrogenase activity, is supportive of 
better fetal and placental growth. Positive associations also were reported between fetal size and pla- 
cental 1 IO-HSD dehydrogenase activity in term rat (23) and human (38) fetuses. Conversely, either 
no association (38) or a negative association (23) existed between placental weight and placental 
1 la-HSD dehydrogenase activity. Discrepancies between human and rat placentae and the current 
data may reflect: 1) stage of placentae, term in humans and rats versus near mid gestation; 2) type 
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ofplacentation, hemochorial versus epitheliochorial; or 3) incubation conditions, homogenates with 
added cofactors versus tissue fragments without exogenous cofactors. 
In this study, one cannot determine the nature of the 11 l3-HSD isoforms responsible for the dehydro- 
genase and oxoreductase activity. We measured NADP’- and NAD’-dependent 11 O-HSD dehydro- 
genase activity in day-75 porcine placentae (26). This suggests the presence of both 1 lg-HSD Type 
I and Type II (39,40), which probably contributed to the measured activities. Indeed, net dehydro- 
genase activity may in part reflect the lower Km (nM range) for cortisol that is prevalent for 1 IR- 
HSD II when compared with the Km of 1 ll3-HSD I for cortisone (pM range). In human placental 
tissue fragments at midterm and late pregnancy (12,18) and in trophoblast cell cultures from term 
placentae (41) oxidative and reductive activities were present with oxidative predominating. In 
baboon (mid to late pregnancy; 42) cultured trophoblast cells had greater dehydrogenase than reduc- 
tase activity. In rat placental fragments, reductase activity was greater at day 16; but on days 19 and 
22, dehydrogenase activity was predominant (27). Such distributions of activities were concordant 
with a strong mRNA expression of 1 ID-HSD Type II and weak expression of 1 ID-HSD Type I in 
human term placentae (43). The profile of 11 R-HSD activity measured in intact rat placentae appears 
to reflect increased mRNA expression of 1 ll3-HSD Type II in the basal zones (17). 
In summary, the current study demonstrates for the first time the presence of 11 D-HSD oxoreductase 
activity in porcine placentae that is substantially less than the dehydrogenase activity under the in 
vitro conditions used. There were strong positive associations between fetal and placental size and 
I lR-HSD net dehydrogenase activity that provide support for the hypothesis that optimal 
glucocorticoid concentrations are supportive of porcine fetal development. 
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